Tiffany Thorn
Founder bei BIVICTRIX THERAPEUTICS PLC
Vermögen: 232 011 $ am 31.03.2024
Profil
Tiffany Thorn is the founder and currently serves as the Chief Executive Officer & Executive Director of BiVictriX Therapeutics Plc, which is founded in 2016.
She previously served as the Chief Executive Officer & Director of Motif Bio Plc.
Ms. Thorn is a graduate of The University of Manchester and holds an undergraduate degree from the University of Lancaster.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2022 | 1 632 500 ( 1,98% ) | 232 011 $ | 31.03.2024 |
Aktive Positionen von Tiffany Thorn
| Unternehmen | Position | Beginn |
|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Founder | 01.01.2016 |
Ehemalige bekannte Positionen von Tiffany Thorn
| Unternehmen | Position | Ende |
|---|---|---|
| MOTIF BIO PLC | Chief Executive Officer | - |
Ausbildung von Tiffany Thorn
| The University of Manchester | Graduate Degree |
| University of Lancaster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
